{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36483911", "DateRevised": {"Year": "2022", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "27"}], "Language": ["eng"], "ELocationID": ["10.17179/excli2022-5376"], "Journal": {"ISSN": "1611-2156", "JournalIssue": {"Volume": "21", "PubDate": {"Year": "2022"}}, "Title": "EXCLI journal", "ISOAbbreviation": "EXCLI J"}, "ArticleTitle": "Nanomedicine and medicinal plants: Emerging symbiosis in managing lung diseases and associated infections.", "Pagination": {"StartPage": "1299", "EndPage": "1303", "MedlinePgn": "1299-1303"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Inflammation, Centenary Institute and University of Technology Sydney; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney 2007, Australia."}], "LastName": "Paudel", "ForeName": "Keshav Raj", "Initials": "KR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia."}, {"Identifier": [], "Affiliation": "Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia."}], "LastName": "De Rubis", "ForeName": "Gabriele", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Inflammation, Centenary Institute and University of Technology Sydney; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney 2007, Australia."}], "LastName": "Panth", "ForeName": "Nisha", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India."}], "LastName": "Singh", "ForeName": "Sachin Kumar", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia."}], "LastName": "Chellappan", "ForeName": "Dinesh Kumar", "Initials": "DK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre of Inflammation, Centenary Institute and University of Technology Sydney; Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney 2007, Australia."}], "LastName": "Hansbro", "ForeName": "Philip Michael", "Initials": "PM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW 2007, Australia."}, {"Identifier": [], "Affiliation": "Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, 2007, Ultimo, Australia."}], "LastName": "Dua", "ForeName": "Kamal", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "EXCLI J", "NlmUniqueID": "101299402", "ISSNLinking": "1611-2156"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Chan Y, Mehta M, Paudel KR, Madheswaran T, Panneerselvam J, Gupta G, et al. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (Lond) 2021;16:1545\u20131548.", "ArticleIdList": ["34184917"]}, {"Citation": "Chan Y, Raju Allam VSR, Paudel KR, Singh SK, Gulati M, Dhanasekaran M, et al. Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases. Crit Rev Food Sci Nutr. 2021;epub ahead of print:1\u201331.", "ArticleIdList": ["34613853"]}, {"Citation": "Chin LH, Hon CM, Chellappan DK, Chellian J, Madheswaran T, Zeeshan F, et al. Molecular mechanisms of action of naringenin in chronic airway diseases. Eur J Pharmacol. 2020;879:173139.", "ArticleIdList": ["32343971"]}, {"Citation": "de Oliveira MTP, de Sa Coutinho D, Tenorio de Souza E, Staniscuaski Guterres S, Pohlmann AR, Silva PMR, et al. Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways. Int J Nanomedicine. 2019;14:5215\u20135228.", "ArticleIdList": ["PMC6636190", "31371957"]}, {"Citation": "Devkota HP, Paudel KR, Jha NK, Gupta PK, Singh SK, Chellappan DK, et al. Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases. Nanomedicine (Lond) 2021;16:2407\u20132410.", "ArticleIdList": ["34670398"]}, {"Citation": "Dhanjal DS, Sharma P, Mehta M, Tambuwala MM, Prasher P, Paudel KR, et al. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases. Future Med Chem. 2022", "ArticleIdList": ["PMC8890134", "35019757"]}, {"Citation": "Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363:2434\u20132443.", "ArticleIdList": ["21158659"]}, {"Citation": "Manandhar B, Paudel KR, Panth N, Hansbro P, Oliver BG, Dua K. Applications of extracellular vesicles as a drug-delivery system for chronic respiratory diseases. Nanomedicine (Lond) 2022;17:817\u2013820.", "ArticleIdList": ["35019729"]}, {"Citation": "Mehta M, Malyla V, Paudel KR, Chellappan DK, Hansbro PM, Oliver BG, et al. Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro. J Food Biochem. 2021;45(11):e13954.", "ArticleIdList": ["34609010"]}, {"Citation": "Mehta M, Paudel KR, Shukla SD, Allam V, Kannaujiya VK, Panth N, et al. Recent trends of NFkappaB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. J Control Release. 2021;337:629\u2013644.", "ArticleIdList": ["34375688"]}, {"Citation": "Mehta M, Paudel KR, Shukla SD, Shastri MD, Satija S, Singh SK, et al. Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation. Future Med Chem. 2021;13:543\u2013549.", "ArticleIdList": ["33538615"]}, {"Citation": "Paudel KR, Jha SK, Allam V, Prasher P, Gupta PK, Bhattacharjee R, et al. Recent advances in chronotherapy targeting respiratory diseases. Pharmaceutics. 2021;13(12):2008.", "ArticleIdList": ["PMC8704788", "34959290"]}, {"Citation": "Paudel KR, Wadhwa R, Mehta M, Chellappan DK, Hansbro PM, Dua K. Rutin loaded liquid crystalline nanoparticles inhibit lipopolysaccharide induced oxidative stress and apoptosis in bronchial epithelial cells in vitro. Toxicol In Vitro. 2020;68:104961.", "ArticleIdList": ["32771431"]}, {"Citation": "Paudel KR, Wadhwa R, Tew XN, Lau NJX, Madheswaran T, Panneerselvam J, et al. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Life Sci. 2021;276:119436.", "ArticleIdList": ["33789146"]}, {"Citation": "Prasher P, Sharma M, Mehta M, Paudel KR, Satija S, Chellappan DK, et al. Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective. Chem Biol Interact. 2020;325:109125.", "ArticleIdList": ["PMC7196551", "32376238"]}, {"Citation": "Rodenak-Kladniew B, Scioli Montoto S, Sbaraglini ML, Di Ianni M, Ruiz ME, Talevi A, et al. Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties. Int J Pharm. 2019;569:118575.", "ArticleIdList": ["31356956"]}, {"Citation": "Solanki N, Mehta M, Chellappan DK, Gupta G, Hansbro NG, Tambuwala MM, et al. Antiproliferative effects of boswellic acid-loaded chitosan nanoparticles on human lung cancer cell line A549. Future Med Chem. 2020;12:2019\u20132034.", "ArticleIdList": ["33124483"]}, {"Citation": "Vijayakurup V, Thulasidasan AT, Shankar GM, Retnakumari AP, Nandan CD, Somaraj J, et al. Chitosan encapsulation enhances the bioavailability and tissue retention of curcumin and improves its efficacy in preventing B[a]P-induced lung carcinogenesis. Cancer Prev Res (Phila) 2019;12:225\u2013236.", "ArticleIdList": ["30760502"]}, {"Citation": "Wadhwa R, Paudel KR, Chin LH, Hon CM, Madheswaran T, Gupta G, et al. Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. J Food Biochem. 2021;45(1):e13572.", "ArticleIdList": ["33249629"]}, {"Citation": "Wang P, Zhang L, Peng H, Li Y, Xiong J, Xu Z. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C Mater Biol Appl. 2013;33:4802\u20134808.", "ArticleIdList": ["24094190"]}, {"Citation": "Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine. 2012;7:3667\u20133677.", "ArticleIdList": ["PMC3414206", "22888226"]}, {"Citation": "Wen ZM, Jie J, Zhang Y, Liu H, Peng LP. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Biochem Biophys Res Commun. 2017;493:1430\u20131437.", "ArticleIdList": ["28958938"]}, {"Citation": "Yen FL, Tsai MH, Yang CM, Liang CJ, Lin CC, Chiang YC, et al. Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-alpha-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathways. PLoS One. 2013;8(5):e63845.", "ArticleIdList": ["PMC3650060", "23671702"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "28"}, {"Year": "2022", "Month": "10", "Day": "25"}, {"Year": "2022", "Month": "12", "Day": "9", "Hour": "4", "Minute": "13"}, {"Year": "2022", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "10", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["36483911", "PMC9727245", "10.17179/excli2022-5376", "2022-5376"]}}], "PubmedBookArticle": []}